Kestra is set to report revenue of $29.01M and a loss of $0.62 per share. Because stronger sales and a wider loss point in opposite directions, this report does not change how we read Kestra.
Kestra will report Q1 results showing revenue of $29.01M and an expected loss of $0.62 per share. Stronger sales and the wider loss pull in opposite directions, so I read this as neutral for Kestra today.
Follow Kestra Medical Technologies, Ltd. (KMTS) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for KMTS